Novartis Investigative Site

Oldsmar, Florida 34677

0 studies enrolling now · 2 studies all time

What they study most

Advancing Multiple Sclerosis, Multiple Sclerosis, Relapsing Multiple Scelrosis, Relapsing Multiple Sclerosis

Studies at this site

• Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients — Completed
• Efficacy and Safety of Ofatumumab Compared to Teriflunomide in Patients With Relapsing Multiple Sclerosis. — Completed